Are American College of Rheumatology 50% response criteria superior to 20% criteria in distinguishing active aggressive treatment in rheumatoid arthritis clinical trials reported since 1997? A meta-analysis of discriminant capacities.
about
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysisSubcutaneous or intramuscular methotrexate for rheumatoid arthritisTocilizumab for rheumatoid arthritisTocilizumab for rheumatoid arthritisBiologics for rheumatoid arthritis: an overview of Cochrane reviewsBiologics for rheumatoid arthritis: an overview of Cochrane reviewsGolimumab for rheumatoid arthritisBiologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review.Brief report: rheumatoid arthritis response criteria and patient-reported improvement in arthritis activity: is an American College of Rheumatology twenty percent response meaningful to patients?The design of a low literacy decision aid about rheumatoid arthritis medications developed in three languages for use during the clinical encounter.Simultaneous Exposure-Response Modeling of ACR20, ACR50, and ACR70 Improvement Scores in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol.Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.Diagnostic value of a 3-day course of prednisolone in patients with possible rheumatoid arthritis - the TryCort study.The number needed to treat for second-generation biologics when treating established rheumatoid arthritis: a systematic quantitative review of randomized controlled trials.Cost utility of tumour necrosis factor-α inhibitors for rheumatoid arthritis: an application of Bayesian methods for evidence synthesis in a Markov model.Short-Term Efficacy Reliably Predicts Long-Term Clinical Benefit in Rheumatoid Arthritis Clinical Trials as Demonstrated by Model-Based Meta-Analysis.The efficacy of the traditional Chinese medicine Juanbi pill combined with methotrexate in active rheumatoid arthritis: study protocol for a randomized controlled trial.
P2860
Q24185797-F4F27CC9-5F96-4883-A6B9-F679656B028CQ24187565-F9F63123-CB5A-437D-85C6-561D832545BEQ24234126-8A990E5C-7F6F-47AE-8532-2D4F5FCED2D5Q24239949-92360FF7-C6EF-45EC-A7F7-244C7968F417Q24240731-62C07D67-CFF6-4A94-8250-1BE16CF0958BQ24240891-16FC1734-4CCF-435A-9CD2-3652A1296F9EQ24240895-83CE944B-EF0E-469B-A6F7-12E70DAF1EFBQ30234528-AB0AEB1E-AFEA-49C5-AF46-6134D306477BQ30235341-53C61D61-12C1-4A08-8CD5-12E68EDFBFD0Q33311301-4786AB49-D582-438E-BF7D-8E7D7B8C2A17Q34098412-9514C6FE-C358-468A-B26B-C1BA8E63F2E0Q35554857-9B34DD0E-BB55-4D4C-9972-4209AE3462F3Q35760130-26C88B47-9EBD-481B-A551-738F188F56D3Q36195284-B5C9F4F0-5C8C-4DC6-A922-2EFCD8DBADB8Q37428436-85D6D52E-562F-416C-AFB3-B1CA36811031Q37740969-BCC3767D-8A75-4E11-BE94-B3C440CEF319Q37800488-83CA2C72-F96E-4730-B232-75486A573D8AQ38013786-1D478FAF-7976-478B-BA06-99201436D2D1Q40374825-E7A0DB7E-B533-42E3-BB15-92E9407094AFQ55000909-A5E38C66-E4A3-425B-B05B-9E71314E92EB
P2860
Are American College of Rheumatology 50% response criteria superior to 20% criteria in distinguishing active aggressive treatment in rheumatoid arthritis clinical trials reported since 1997? A meta-analysis of discriminant capacities.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Are American College of Rheuma ...... is of discriminant capacities.
@ast
Are American College of Rheuma ...... is of discriminant capacities.
@en
type
label
Are American College of Rheuma ...... is of discriminant capacities.
@ast
Are American College of Rheuma ...... is of discriminant capacities.
@en
prefLabel
Are American College of Rheuma ...... is of discriminant capacities.
@ast
Are American College of Rheuma ...... is of discriminant capacities.
@en
P2093
P2860
P356
P1476
Are American College of Rheuma ...... is of discriminant capacities.
@en
P2093
P2860
P304
P356
10.1136/ARD.2005.048975
P407
P577
2006-02-27T00:00:00Z